title: PARP inhibition in ovarian cancer: state of the science.
authors.affiliation: University of Oklahoma Health Sciences Center, Stephenson Cancer Center, 800 NE 10th Street, Suite 5040, Oklahoma City, Oklahoma 73104. Electronic address: camille-gunderson@ouhsc.edu.
authors.forename: Camille C
authors.initials: CC
authors.lastname: Gunderson
authors.affiliation: University of Oklahoma Health Sciences Center, Stephenson Cancer Center, 800 NE 10th Street, Suite 5040, Oklahoma City, Oklahoma 73104. Electronic address: kathleen-moore@ouhsc.edu.
authors.forename: Kathleen N
authors.initials: KN
authors.lastname: Moore
mesh_terms: D017322:Clinical Trials, Phase II as Topic; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000201:enzymology*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D016032:Randomized Controlled Trials as Topic
chemical_list: D004791:Enzyme Inhibitors; D000067856:Poly(ADP-ribose) Polymerase Inhibitors